Insurance coverage for Wegovy depends on: BMI 30, or 27 with weight-related conditions Prior authorization required Medical necessity documentation needed Coverage varies by insurer Wegovy can reduce hunger-driven binge eating through appetite suppression, but treatment requires oversight from eating disorder specialists
Pharmacological research shows that semaglutide reduces salivary function
Consistent with observations in subjects with mild-to-severe renal impairment, there appeared to be no effect on semaglutide exposure in subjects requiring haemodialysis
GLP-1 therapy is not appropriate for everyone and carries risks including pancreatitis, gallbladder disease, and contraindications such as a personal or family history of medullary thyroid carcinoma or MEN2
pentadecapeptide BPC 157 200 g/kg b.w
If you are looking to lose 10-15 pounds, medication might be an option